Asia-Pacific inflation device market is projected to register a steady CAGR in the forecast period of 2019 to 2026. The new market report contains data for the historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.
Market Segmentation:
By Type (Analogue Inflation Device, Digital Inflation Devices), Application (Interventional Cardiology, Interventional Radiology, Peripheral Vascular Procedures, Gastroenterological Procedures, Urological Procedures, Others), Capacity (20ml Inflation Devices, 25ml Inflation Devices, 30ml Inflation Devices, 60ml Inflation Devices), Function (Fluid Delivery, Stent Deployment), End User (Hospitals, Clinics, Interventional Laboratories), Distribution Channel (direct, retail), Country (China, Japan, India, Australia, Singapore, Indonesia, Thailand, South Korea, Malaysia, Philippines, New Zealand, Vietnam, Rest of Asia-Pacific)
Some of the major factors contributing to the growth of the Asia-Pacific inflation device market are:
> Improving healthcare infrastructure
> Increasing aging age population.
Market Players:
The key market players for Asia-Pacific inflation device market are listed below:
> Boston Scientific Corporation
> Olympus Corporation
> Medtronic
> Teleflex Incorporated
> Conmed Corporation
> Merit Medical Systems
> B. Braun Melsungen AG
> BD
> Advanced Lifesciences PVT. LTD.
> Acclarent, Inc.
> Accura
> SMT
> Elite Medtek (Jiangsu) Co. Ltd
> Atrion Corporation
> US Endovascular
> Smiths Group plc
> Nucryo Vascular LLC
> Spectrum Medtech Pvt. Ltd
> Beijing Demax Medical Technology Co.,Ltd
> Cook
> Medorah Meditek Pvt. Ltd.
> Perouse Medical